AIBIOS Funding & Investors
Irvine, CA
AIBIOS has designed and developed a series of novel small molecules which modulate both the innate (macrophages) and adaptive immune system to treat therapeutic indications of Gastroenterology, Respiratory, and Neurological diseases.
aibios.comTotal Amount Raised: $850,000,000
AIBIOS Funding Rounds
Seed
500,000,000 JPY
Seed Investors
SBI Investment Co.Seed
350,000,000 JPY
Funding info provided by Diffbot.